Effects of T lymphocytes, interleukin-1, and interleukin-6 on renal fibrosis in canine end-stage renal disease

Journal of Veterinary Diagnostic Investigation

Volumn 20, Issue 5, 2008, Pages 585-592

  Yhee, Ji Young ^a   Yu, Chi Ho ^a   Kim, Jong Hyuk ^a   Sur, Jung Hyang ^a  

^a Konkuk University   (South Korea)

Author keywords

Canine; Fibrosis; Immunohistochemistry; Interleukin 1; Interleukin 6; Kidney failure; T lymphocytes

Indexed keywords

CANIS FAMILIARIS;

INTERLEUKIN 1; INTERLEUKIN 6;

ANIMAL; ANIMAL DISEASE; ARTICLE; B LYMPHOCYTE; CHRONIC KIDNEY FAILURE; DOG; DOG DISEASE; FIBROSIS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KIDNEY; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; DOG DISEASES; DOGS; FIBROSIS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; INTERLEUKIN-6; KIDNEY; KIDNEY FAILURE, CHRONIC; T-LYMPHOCYTES;

EID: 55449088676     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870802000508     Document Type: Article

References (26)

1. Bertolini JN, Benson EM: 1990, The role of human interleukin-6 in B-cell isotype regulation and differentiation. Cell Immunol 125:197-209.
2. Bohle A, Mackensen-Haen S, von Gise H: 1987, Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. Am J Nephrol 7:421-433.
3. Cowley LV: 2001, An introduction to human disease: pathology & pathophysiology correlations, 5th ed., pp. 670-671. Jones & Bartlett, London, UK.
4. Duncan MR, Berman B: 1991, Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 97:686-692.
5. Edwards JC, Cambridge G: 2006, B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 6:394-403.
6. Goldby RA, Kindt TJ, Osborne BA, et al.: 2002, Immunology, 5th ed., pp. 281, 236-237. Freeman and Company, New York, NY.
7. Grimm PC, Nickerson P, Jeffery J, et al.: 2001, Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 345:93-97.
8. Hasegawa M, Fujimoto M, Takehara K, et al.: 2005, Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. J Dermatol Sci 39:1-7.
9. Heller F, Lindenmeyer MT, Cohen CD, et al.: 2007, The contribution of B cells to renal interstitial inflammation. Am J Pathol 170:457-468.
10. Iwano M, Plieth D, Danoff TM, et al.: 2002, Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350.
11. Jennette JC, Olson JL, Schwartz MM, et al.: 2005, Heptinstall's pathology of the kidney, 5th ed., pp. 1372-1407. Lippincott-Raven, Philadelphia, PA.
12. Jones TC, Hunt RD, King NW: 1997, Veterinary pathology, 6th ed., pp. 935-996. Williams & Wilkins, Baltimore, MD.
13. Liu B, Connolly MK: 1998, The pathogenesis of cutaneous fibrosis. Semin Cutan Med Surg 17:3-11.
14. Lonnemann G, Shapiro L, Engler-Blum G, et al.: 1995, Cytokines in human renal interstitial fibrosis, I: interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney Int 47:837-844.
15. Nordan R, Potter M: 1986, A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science 233:566-569.
16. Poulsom R, Forbes SJ, Hodivala-Dilke K, et al.: 2001, Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 195:229-235.
17. Poupart P, Vandenabeele P, Cayphas S, et al.: 1987, B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF). EMBO J 6:1219-1224.
18. Ray A, Tatter SB, Santhanam U, et al.: 1989, Regulation of expression of interleukin-6: molecular and clinical studies. Ann N Y Acad Sci 557:353-362.
19. Strehlow D, Korn JH: 1998, Biology of the scleroderma fibroblast. Curr Opin Rheumatol 10:572-578.
20. Strutz F, Neilson EG: 2003, New insight into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol 24:459-476.
21. Strutz F, Zeisberg M: 2006, Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 17:2992-2998.
22. Tang JT, Fang JY, Gu WQ, et al.: 2006, T cell immune response is correlated with fibrosis and inflammatory activity in hepatitis B cirrhotics. World J Gastroenterol 12:3015-3019.
23. Tashbaeva RE, Hwang DN, Song GS, et al.: 2007, Cellular characterization of multidrug resistance P-glycoprotein, alpha fetoprotein, and neovascular endothelium-associated antigens in canine hepatocellular carcinoma and cirrhotic liver. Vet Pathol 44:600-606.
24. Uitto J, Bauer EA, Eisen AZ: 1979, Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest 64:921-930.
25. Van Snick J: 1990, Interleukin-6: an overview. Annu Rev Immunol 8:253-278.
26. Wynn TA: 2007, Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117:524-529.